Judge blocks class certification against Takeda, Teva and others

A Pennsylvania federal judge has refused to certify a class of wholesale purchasers of a gout treatment medicine, finding that the claim against several major drugmakers is based on faulty expert testimony that does not hold up to rigorous analysis.